These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37460861)

  • 21. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
    Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
    BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
    Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
    Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a pro-protein synthesis osteosarcoma subtype for predicting prognosis and treatment.
    Yi C; Liu J; Zhao S; Gong D; Xu B; Li A; Bian E; Tian D
    Sci Rep; 2024 Jul; 14(1):16475. PubMed ID: 39014082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
    Zhou X; Zhao M; Fan Y; Xu Y
    PeerJ; 2024; 12():e16616. PubMed ID: 38213773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
    Wu ZY; Shi ZY
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
    Liu B; Liu XY; Wang GP; Chen YX
    Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
    Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
    Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
    Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
    Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 34. An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer.
    Shi H; Peng Q; Zhou X; He Y; Sun S
    Front Genet; 2022; 13():848747. PubMed ID: 35419022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival.
    Gong L; Sun X; Jia M
    Sci Rep; 2023 Oct; 13(1):18271. PubMed ID: 37880378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
    Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
    J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer.
    Yang Z; Li J; Tang Y; Zou L
    Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer.
    Xin D; Man Y; Yang Y; Wang F
    Front Genet; 2022; 13():953997. PubMed ID: 36092932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.